All About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott

Similar documents
FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

Gavi s strategic framework 22 June 2016

DIARRHEAL DISEASE MESSAGING

Global Health Policy: Vaccines

How to present the European Vaccine Action Plan (EVAP)

STATEMENT OF LYNN STRATFORD SENIOR VICE PRESIDENT, PROGRAM AND COMMUNITY ENGAGEMENT UNITED STATES FUND FOR UNICEF

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

Ministry of health. Our Community

Polio and routine immunisation Alan Brooks

Global Health Policy: Vaccines

Polio Eradication Rotary s Commitment & Global Partnership. Carol Wells District 6440 EPN Chair

GAVI Role in IPV Introductions

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

1. The World Bank-GAVI Partnership and the Purpose of the Review

Gavi Alliance Strategy : Goal level indicators and disease dashboard

Polio & routine immunisation Alan Brooks

A Briefing Paper on Rotavirus

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

Why does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

Common Virus and Senseless Killer: A Briefing Paper on Rotavirus

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

GAVI, THE VACCINE ALLIANCE

polio STRATEGY OVERVIEW

VACCINE MARKETS OVERVIEW SESSION

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

GAVI Alliance Demand-side Innovation Policies

Global Partners' Group

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION.

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

Polio post-certification strategy

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

KURUKSHETRA JULY 2017 RURAL HEALTH

Global Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva

VERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance

Access to vaccination in GAVI countries and at global level

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

The power of partnership: the GAVI Alliance Board

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

Paradigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance

Ex post evaluation India

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010

Gavi s private sector engagement approach

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Ex Post-Evaluation Brief India: Polio Immunisation Programme, Phases I to VII

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

The power of innovation to save lives

A C T I O N T O A D D R E S S P N E U M O N I A A N D D I A R R H O E A

Global measles and polio initiative

Why GAVI Needs to Do More To Ensure Lower Vaccine Prices And How It Could Be Done

PNEUMONIA REPORT CARD TUESDAY, NOVEMBER 9, 2010 EMBARGOED UNTIL NOVEMBER 12, 2010

Monitoring results: goals, strategic objectives and indicators

Gavi Secretariat Update: Progress, priorities and strategies

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Rotavirus. Factsheet for parents. Immunisation for babies up to a year old

Update on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 5. Can my country afford a JE vaccination program?

What is to be done to respond to country needs and comply with WHA and SAGE recommendations?

USAID Progress: The U.S. National Vaccine Plan of 1994

Strategies to Control Pneumonia and Diarrhoea: Tackling the deadliest diseases for the world s poorest children

topv to bopv FACTSHEET 25 APRIL 2016

Report to the Board 6-7 June 2018

The Global Alliance for Improved Nutrition

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

Accelerating the Introduction of Rotavirus Vaccines into GAVI-Eligible Countries

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD

For Health Worldwide Financing Gavi, the Vaccine Alliance as an investment in the future

1 We need to invest more in vaccines

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

Creating VaCCines, ProteCting Life

Report to the. GAVI Alliance Board June 2013

County of Santa Cruz. General Questions About Measles HEALTH SERVICES AGENCY. Public Health Division. What is measles?

World Immunization Week 2013

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

GAVI, THE VACCINE ALLIANCE

Report on MCSP Support for the Polio Switch in April 2016

Check out a recording of s kick-off webinar at bit.ly/a2v2018 to learn about the easy ways you/your network can get involved!

Presentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura

Innovative Finance: the power of innovation to save lives

Polio Vaccine. By: Lia Schmitz, Pharm.D. Poliomylitis is a viral infection for which vaccination is generally given

Ex post evaluation Tanzania

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

For information on programmes in other countries and regions please access the Federation website at Programme title 2005

Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets

TALKING POINTS INTRODUCTION

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

Gavi initiatives for improving vaccine supply

Why still Polio Donato Greco ECDC polio consultant 14 April 2016

GAVI s Financing for Pneumococcal Vaccines, including the Advance Market Commitment

Transcription:

All About Vaccines and How They Get to Those Who Need Them Most Elesha Kingshott

Shot@Life Four Priority Disease Areas 1. Polio 2. Measles 3. Diarrheal Disease 4. Pneumonia

Polio is caused by a virus that infects the human digestive tract 3 types: wild poliovirus (WPV) 1, 2, and 3 Most cases are asymptomatic; 1 in 200 results in paralysis. 5-10% of those paralysis cases result in death

Polio Vaccine There are two types of vaccines to protect against polio Inactivated Polio Vaccine is given through an injection and protects against all three strains of wild polio virus Oral Polio Vaccine is a weekend virus but not killed it contains all 3 strains

1988: 350,000 cases worldwide 2016: 37 cases worldwide The disease remains endemic in just 3 countries: Afghanistan, and Nigeria, Pakistan This enormous progress is the result of global efforts to eradicate the disease, led by the Global Polio Eradication Initiative (GPEI) We can finish the fight and end polio this year! Update on Polio

Measles Measles is caused by a virus that infects the respiratory system, immune system, and skin Measles is an airborne disease In communities with low immunization rates, a person infected with measles can infect up to 18 other people

Measles Symptoms Measles symptoms include, high fever, cough, runny nose, conjunctivitis and rash. Measles can have severe complications like pneumonia, diarrhea, and blindness.

Measles has different outcomes depending on where you live High-income Countries Low-income Countries 1 in 4 people who get measles will be hospitalized. 1 out of 1,000 people with measles will develop encephalitis, which can lead to brain damage. 1 or 2 out of 1,000 people with measles will die, even with the best care.

Update on Measles Two doses are about 97% effective. Since 2000, 20 million lives have been saved because of measles vaccines. Measles vaccines are the single greatest contribution to reducing child deaths since 2000.

Virus that infects the small intestine and causes diarrhea Nearly every child in the world will suffer a rotavirus infection by their third birthday. Worldwide 37% of hospitalizations for diarrhea in children under five are due to rotavirus. Rotavirus kills 450,000 children under 5 every year Rotavirus

Cannot be treated with antibiotics Treatment involves oral rehydration therapy through oral rehydration solution (ORS) and zinc treatment In low-income countries in Africa and Asia access to treatment for severe rotavirus-related diarrhea is limited or unavailable Rotavirus

Rotavirus Vaccine In 2006 and 2008, two oral rotavirus vaccines entered the market By the end of 2015, more than 36 million children in low-income countries had been immunized with rotavirus vaccine

Rotavirus Introductions by WHO Region

Children are most affected Leading cause of childhood pneumonia It is the leading vaccine-preventable cause of death in children under five years of age Most common in developing countries, where 90% of kids are infected by age 5 and the first infection happens at 1-2 months of age Most pneumococcal disease is caused by just 7 strains Pneumococcal Disease

Children are most affected Leading cause of childhood pneumonia It is the leading vaccine-preventable cause of death in children under five years of age. Most common in developing countries, where 90% of kids are infected by age 5 and the first infection happens at 1-2 months of age Most pneumococcal disease is caused by just 7 strains Pneumococcal Disease

Update on Pneumococcal Vaccines Leading cause of death of children under 5 in the developing world Pneumococcal vaccines are made accessible to those who need them most through innovative financing mechanisms designed and implemented by Gavi

Update on Pneumococcal Vaccines: Vaccine Introductions Rollouts began in 2009 Since then, pneumococcal vaccines have been introduced in 50 countries worldwide Gavi and its partners have immunized more than 70 million children with pneumococcal vaccines

Shot@Life s Partners World Health Organization UNICEF Gavi, the Vaccine Alliance

World Health Organization WHO s primary role is to direct and coordinate international health within the United Nations system In low-income countries, WHO serves a vital role in ensuring UN programs are coordinated with the ministry of health

World Health Organization Areas of work on Immunization: WHO policy recommendations Overseeing global vaccination goals Strengthening national programs and systems Monitoring and surveillance Quality, safety and standards Research and development

UNICEF Vaccine Procurement UNICEF is the world s largest buyer of childhood vaccines, reaching over 40% of the world s children. In 2014, UNICEF procured 2.71 billion vaccine doses for children in 100 countries.

UNICEF s Work Beyond Procurement UNICEF invests and manages the cold chain to make sure vaccines are kept at the right temperature. They lead the demand generation for vaccination in most countries to educate families about the need to get immunized.

Gavi, the Vaccine Alliance Gavi raises and distributes funds for childhood immunization in the world s poorest countries Gavi works with the 54 world s poorest countries to ensure access to 11 vaccines Countries have to have a per capita Gross National Income below or equal to US$ 1,580 on average over the past three years

Gavi, the Vaccine Alliance Gavi s model focuses on pooling funds from donors for immunization, and pooling demand to negotiate for lower vaccine prices on behalf of Gavi-eligible countries Countries have to co-finance a portion of each vaccine to help ensure sustainability and country ownership

How it All Comes Together: UNICEF Example A Champion donates $ to S@L UNF grants to UNICEF UNICEF Supply Division buys the vaccine UNICEF ships the vaccine to the country The vaccine is delivered to the health system through the cold chain A child is taken to get vaccinated UNICEF works with families on the ground to generate demand for vaccination WHO works with MOH to ensure quality and safety standards are met